Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Autoimmune: Page 2
Aptorum provides update on its rapid MDx technology
By
LabPulse.com staff writers
The technology has been clinically validated in more than 100 patient samples, Aptorum said.
September 14, 2022
Prometheus, Takeda launch prognostic tool for Crohn’s
By
LabPulse.com staff writers
According to Prometheus, CDPath is a personalized risk assessment tool that can be used in combination with a physician's clinical assessment to evaluate an adult patient's risk for developing serious complications of CD such as bowel strictures, internal penetrating disease, or non-perianal surgery within three years.
September 14, 2022
Nordic touts PRO-C6 biomarker for heart failure clinical trials
By
LabPulse.com staff writers
In collaboration with Bristol Myers Squibb and the University of Pennsylvania, researchers combined analyses of six independent cohorts of HFpEF patients from around the globe, which are being evaluated with the PRO-C6 biomarker.
September 13, 2022
N-antigen levels point to COVID severity in NIH study
By
Jared Berberabe
The study by researchers at the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) was a cross-sectional follow-up analysis involving 2,540 participants who had been previously enrolled in the Therapeutics for Inpatients with COVID-19 (TICO) platform trial.
September 8, 2022
Lunaphore, Nucleai to provide AI-based spatial biology analysis
By
LabPulse.com staff writers
Combining Lunaphore's Comet hyperplex staining and imaging platform, a fully automated sequential immunofluorescence (seqIF) instrument, with Nucleai's Atom artificial-intelligence (AI) spatial biology platform will enable the companies to generate new insights from tissue biopsies and provide labs with an integrated end-to-end spatial biology workflow.
September 8, 2022
Week in Review: At-home flu testing, asymptomatic monkeypox, telediagnostic accuracy, and more
By
Leo O'Connor
Dear LabPulse.com member,
September 7, 2022
IsoPlexis joins MediMergent, CCBD for COVID-19 study
By
LabPulse.com staff writers
The large multisite study will focus on the functionality of immune cells and their role in prevention of breakthrough COVID-19 infections in immunocompromised patients following administration of AstraZeneca's AZD7442 IM or IV antibody combination.
September 5, 2022
NfL IDs patients predisposed to neurotoxic complications
By
LabPulse.com staff writers
Analyzing blood samples from patients before, during, and after CAR-T cell therapy, Washington University School of Medicine researchers found that levels of neurofilament light chain (NfL) proteins are higher in patients who develop neurotoxic complications.
August 31, 2022
Week in Review: Room-temperature CRISPR, Roche T-cell test for COVID response, Qiagen monkeypox syndromic panel, and more
By
Leo O'Connor
Dear LabPulse.com member,
August 17, 2022
3M divides health, oral care division into new business
Its new standalone healthcare business will focus on oral care, wound care, healthcare information technology, and biopharma filtration. The tax-free transaction is expected to close by the end of 2023. 3M's healthcare sector generated approximately $8.6Â billion in sales in 2021, according to the company.
July 27, 2022
Drug test detects possibly toxic cannabis derivative
By
LabPulse.com staff writers
Breaking research showcased on Tuesday at AACC 2022 demonstrates that common drug testing methods can do just that.
July 26, 2022
Labcorp NfL test confirms neurodegenerative disease
By
LabPulse.com staff writers
The neurofilament light chain (NfL) blood test will allow doctors to identify and verify signs of neurodegenerative disease, enabling physicians to provide a more effective and efficient path to diagnosis and treatment for patients, the firm said.
July 12, 2022
Previous Page
Page 2 of 9
Next Page
